Title: CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric
intestinal metaplasia
Version: 5 Date: 23 Mar 2022
Reviewer's report:
I'm afraid to say that I'm still not convinced that the methodology used in the study allows you
to reach any reliable conclusion without increasing the number of cases.
Title: CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric
intestinal metaplasia
Version: 5 Date: 23 Mar 2022
Reviewer's report:
I'm afraid to say that I'm still not convinced that the methodology used in the study allows you
to reach any reliable conclusion without increasing the number of cases.
Please review this paper.
user
Title: CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric
intestinal metaplasia
Version: 5 Date: 23 Mar 2022
Reviewer's report:
I'm afraid to say that I'm still not convinced that the methodology used in the study allows you
to reach any reliable conclusion without increasing the number of cases.
assistant